.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Moodys
Covington
AstraZeneca
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Cerilliant
Federal Trade Commission

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,259,539

« Back to Dashboard

Which drugs does patent 9,259,539 protect, and when does it expire?


Patent 9,259,539 protects AUVI-Q and is included in one NDA.

This patent has one hundred patent family members in fourteen countries.

Summary for Patent: 9,259,539

Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a label configured to be coupled to a medicament delivery device. The label includes a first surface and a second surface. The first surface is configured to be coupled to an outer surface of the medicament delivery device. The second surface includes a textual indicia. The label further includes an electronic circuit system configured to output an electronic signal.
Inventor(s): Edwards; Eric S. (Moseley, VA), Edwards; Evan T. (Charlottesville, VA), Licata; Mark J. (Doswwell, VA), Meyers; Paul F. (Fishers, IN), Weinzierl; David A. (Andover, MN)
Assignee: kaleo, Inc. (Richmond, VA)
Application Number:14/470,165
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► Subscribe► SubscribeY
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 9,259,539

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,361,029Devices, systems and methods for medicament delivery► Subscribe
8,313,466Devices, systems and methods for medicament delivery► Subscribe
7,918,823Devices, systems and methods for medicament delivery► Subscribe
8,544,645Devices, systems and methods for medicament delivery► Subscribe
9,278,182Devices, systems and methods for medicament delivery► Subscribe
9,327,077Medical injector with compliance tracking and monitoring► Subscribe
8,226,610Medical injector with compliance tracking and monitoring► Subscribe
9,278,177Medical injector with compliance tracking and monitoring► Subscribe
9,238,108Medicament delivery device having an electronic circuit system► Subscribe
8,123,719Devices, systems and methods for medicament delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 9,259,539

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2008520339► Subscribe
United Kingdom0708523► Subscribe
United Kingdom2434548► Subscribe
United Kingdom0713202► Subscribe
United Kingdom2440039► Subscribe
United Kingdom0815343► Subscribe
United Kingdom2449027► Subscribe
United Kingdom0818178► Subscribe
United Kingdom2451769► Subscribe
United Kingdom0822532► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Farmers Insurance
Teva
Harvard Business School
AstraZeneca
Chinese Patent Office
Queensland Health
Daiichi Sankyo
Mallinckrodt
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot